Assessing the Revised Safer Dx Instrument^® in the understanding of ambulatory system design changes for type 1 diabetes and autism spectrum disorder in pediatrics.

ABSTRACT:

Objectives

We sought within an ambulatory safety study to understand if the Revised Safer Dx instrument may be helpful in identification of diagnostic missed opportunities in care of children with type 1 diabetes (T1D) and autism spectrum disorder (ASD).

Methods

We reviewed two months of emergency department (ED) encounters for all patients at our tertiary care site with T1D and a sample of such encounters for patients with ASD over a 15-month period, and their pre-visit communication methods to better understand opportunities to improve diagnosis. We applied the Revised Safer Dx instrument to each diagnostic journey. We chose potentially preventable ED visits for hyperglycemia, diabetic ketoacidosis, and behavioral crises, and reviewed electronic health record data over the

SUBMITTER: Brady PW 

PROVIDER: S-EPMC11306753 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature